Our findings highlight the important regulatory role of acetylation signaling in the PCAF–ISX–BRD4 axis to promote EMT initiation and regulation during tumor metastasis, highlighting its potential as a therapeutic target for prevention of EMT and metastasis. The gene discussed is KAT2B; the disease is neoplasm.